Louis Émile Javal
French ophthalmologist known for his work on strabismus and reading disorders
Louis Émile Javal (5 May 1839 – 20 January 1907) was a French ophthalmologist renowned for his pioneering work in the study of strabismus and reading disorders. He made significant contributions to the understanding of eye movements and binocular vision.
Early life and education[edit]
Louis Émile Javal was born in Paris, France, into a family of Alsatian origin. He pursued his medical studies in Paris, where he developed an interest in ophthalmology. Javal's early work focused on the mechanics of eye movements and the physiology of vision.
Career[edit]
Javal became a professor of ophthalmology and directed the ophthalmology laboratory at the Sorbonne. His research was instrumental in advancing the understanding of strabismus, a condition where the eyes do not properly align with each other when looking at an object. He developed several devices to measure and correct strabismus, including the Javal-Schiötz ophthalmometer, which is used to measure the curvature of the cornea.

Contributions to ophthalmology[edit]
Javal's work extended beyond strabismus to include the study of reading disorders. He was one of the first to systematically study the movements of the eyes during reading, known as saccades. His observations laid the groundwork for future research into dyslexia and other reading difficulties.
Javal also contributed to the development of orthoptics, a field of vision therapy aimed at improving binocular vision and treating disorders such as strabismus and amblyopia.
Legacy[edit]
Louis Émile Javal's contributions to ophthalmology have had a lasting impact on the field. His work on eye movements and reading disorders continues to influence research and clinical practice today. The Javal-Schiötz ophthalmometer remains a valuable tool in the diagnosis and management of corneal conditions.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian